FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Fresenius Kabi Epinephrine Injection Recall

Epinephrine Injection, USP, 1mg/mL, 1 mL single-dose vial, Rx only, Fresenius Kabi, Lak…

Fresenius Kabi USA, LLC · Lake Zurich, IL

Risk level
Class III
Reported by FDA
Jun 17, 2026
Recall ID
D-0581-2026
Check your lot numberHow we source this data

Summary

Fresenius Kabi recalled Epinephrine Injection starting May 14, 2026. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0581-2026 on Jun 17, 2026. Reason: Failed Impurities/Degradations Specifications. Status: Ongoing.

Why it was recalled

Failed Impurities/Degradations Specifications

Product description

Epinephrine Injection, USP, 1mg/mL, 1 mL single-dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-696-02 (vial), NDC 63323-696-25 (carton)

Lot numbers, UPCs & expiration codes

Batch # 6133313, 6133314, Exp Date: 06/2026; Batch # 6133315, Exp Date: 07/2026; Batch # 6133682, Exp Date: 09/2026; Batch # 6134812, 6134813, Exp Date: 04/2027.

Where it was sold

US Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0581-2026
Classification
Class III
Status
Ongoing
Recall initiated
May 14, 2026
FDA report date
Jun 17, 2026
Quantity
898,050 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Fresenius Kabi USA, LLC

Original FDA data

Every field from FDA enforcement report D-0581-2026, exactly as published.

Show all FDA fields
City
Lake Zurich
State
IL
Status
Ongoing
Country
United States
Event ID
98997
Address
3 Corporate Dr
Code information
Batch # 6133313, 6133314, Exp Date: 06/2026; Batch # 6133315, Exp Date: 07/2026; Batch # 6133682, Exp Date: 09/2026; Batch # 6134812, 6134813, Exp Date: 04/2027.
Postal code
60047-8930
Report date
Jun 17, 2026
Product type
Drugs
Recall number
D-0581-2026
Classification
Class III
Recalling firm
Fresenius Kabi USA, LLC
Product quantity
898,050 vials
Reason for recall
Failed Impurities/Degradations Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Epinephrine Injection, USP, 1mg/mL, 1 mL single-dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-696-02 (vial), NDC 63323-696-25 (carton)
Distribution pattern
US Nationwide.
Recall initiation date
May 14, 2026
Initial firm notification
Letter
Center classification date
Jun 5, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0581-2026, published Jun 17, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls